drugset / Trial / NCT03004469
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.
Timeline
- Start
- 2016-08-02
- Primary completion
- 2018-03-05
- Completion
- 2018-03-05
Outcome
Met primary endpoint
registry P-3074 + Finasteride Placebo vs P-3074 Vehicle + Finasteride Placebo; p <.001; LS Mean Difference 13.6 (95% CI 5.8 to 21.3) NCT03004469 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Finasteride | Small molecule | 1 mg | Oral |
| Subject | P-3074 | Unknown | 0.25 % | Topical |